Companies: 10,795·Total market cap: $144.5T

Zymeworks Inc.

Zymeworks Inc.

ZYMENASDAQHealthcare● Active

$23.77

$-0.27(-1.11%)

Market Cap$1.7B

P/E Ratio—

52W High$29.75

52W Low$11.51

Avg Volume687K

Open$23.94

Beta1.14

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Zymeworks Inc.（ZYME）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ZYME · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.37Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$81.3MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding75.3MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Zymeworks Inc. 数据

分析师预测$42 · Buy

股息不分红

营收$106.0M+38.87%

盈利EPS $-1.08+33.33%

财务快照

FY 2025Revenue$106.0M▲ +38.87% YoY

202320242025

FY 2025Net Income-$81.1M▲ +33.88% YoY

202320242025

FY 2025EPS$-1.08▲ +33.33% YoY

202320242025

TTM:Revenue: $81.3MNet Income: -$102.7MEPS: $-1.37View income statement →

分析师评级与目标价

Buy20 位分析师

Strong Buy

0

Buy

18

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$33.00Low

$23.77Current

$41.75Avg Target上涨空间 75.61%

$48.00High

合计: 20 · 买入占比: 90.0%

根据过去 3 个月内 20 位华尔街分析师，ZYME 共识评级为 Buy，12 个月平均目标价 $41.75 （较现价 $23.77 上涨空间 75.61%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$23.77-1.11%$1.7B #2

$5.60+0.63%$1.4B #3

BioCryst Pharmaceuticals, Inc.

$8.30-0.89%$1.7B #4

$18.55+0.03%$1.8B #5

Maze Therapeutics, Inc.

$23.80-1.75%$1.3B #6

Intellia Therapeutics, Inc.

$13.44-0.04%$1.5B

股票表现

1D-1.12%

1W-2.26%

1M-0.50%

3M-1.29%

YTD-9.72%

1Y+90.92%

5Y-33.06%

关于 Zymeworks Inc.

CEOKenneth H. Galbraith

IPO DateApr 28, 2017

Employees299

CountryCA

Websitezymeworks.com

Zymeworks Inc. a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatam…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

Zymeworks Inc.（ZYME）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 28, 2017 在 NASDAQ 上市。截至最近交易日，ZYME 股价为 $23.77，市值约为 $1.7B。过去12个月累计回报 +90.92%，年初至今回报 -9.72%。

根据 20 位华尔街分析师，Zymeworks Inc. 股票共识评级为Buy，12个月平均目标价为 $41.75。2025 财年 Zymeworks Inc. 营收 $106.0M，净利润 -$81.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Zymeworks Inc.（ZYME）股价为 $23.77，在 NASDAQ 上市，52周区间为 $11.51 – $29.75。

ZYME 最新股价ZYME quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议